2010 SEP 7 ... Scientists discuss in 'HIV-1 proviral resistance mutations: usefulness in clinical practice' new findings in ... proviral resistance mutations: usefulness in clinical practice' new findings in HIV/AIDS. According to a study from Brussels, Belgium, "Transmitted HIV strains may harbour drug ... protease inhibitor (PI)-or nonnucleoside reverse transcriptase inhibitor (NNRTI)-based therapy initiation in 69 drug-naive patients. Before therapy, 90 and 66% of detected mutations ...
2010 SEP 7 ... in pregnancy: balancing the risk of preterm delivery with prevention of mother-to-child HIV transmission.' "Highly active antiretroviral therapy (HAART) for pregnant HIV-positive ... UK. Keywords: Country:United Kingdom, Antiviral, HIV Infections, HIV/AIDS, Pediatrics, Primate Lentiviruses, RNA Viruses, Retroviridae, Treatment, Vertebrate ...
2010 SEP 7 ... New investigation results, 'Estimating the optimal CD4 count for HIV-infected persons to start antiretroviral therapy,' are detailed in a study published in ... These studies compared the effect of starting HAART on mortality and mortality/AIDS between strata defined using broad ranges of CD4 counts," scientists in the United ...
2010 SEP 7 ... (time of DOT-HAART completion) we measured depression, social support, quality of life, HIV-related stigma and self-efficacy. We compared 12 month clinical and psychosocial ... in HIV-associated stigma." Munoz and colleagues published their study in Aids and Behavior (Community-based DOT-HAART accompaniment in an urban resource-poor setting. ... Peru, "From December 2005 to April 2007, we enrolled 60 adults starting antiretroviral therapy (ART) in a health district of Lima, Peru to receive community-based accompaniment with ...
2010 SEP 7 ... (ARVs) used for treatment or prophylaxis in a breastfeeding population of HIV-1-infected women (Burkina-Faso, Kenya, South Africa). HIV-1-infected pregnant women with ... USA. Keywords: City:Geneva, Country:Switzerland, HIV Infections, HIV/AIDS, Microbiological Techniques, Nevirapine, Pediatrics, Primate Lentiviruses, RNA Viruses, ... were enrolled in a parallel randomized trial. Women in cohort A initiated antiretroviral therapy. Women in cohort B received zidovudine from 34 to 36 weeks gestation until delivery, ...
2010 SEP 7 ... retained their protective effect. An increased risk of WGS >2 was linked to higher HIV RNA values (maximum risk at >5 log(10) copies/mL) and nevirapine exposure; CD4 counts ... degli Studi, Milan, Italy. Keywords: City:Milan, Country:Italy, HIV, HIV/AIDS, Primate Lentiviruses, RNA Viruses, Retroviridae, Vertebrate Viruses. This ... a study "To evaluate whether etravirine (TMC125) might be effective in patients failing therapy with current nonnucleoside reverse transcriptase inhibitors (NNRTIs), we analysed the ...
2010 SEP 7 ... jirovecii prophylaxis discontinuation based upon total lymphocyte count in HIV-infected adults treated with antiretroviral therapy.' "Pneumocystis jirovecii ... Cheung and colleagues published their study in International Journal of Std & Aids (Pneumocystis jirovecii prophylaxis discontinuation based upon total lymphocyte count in ...
2010 SEP 7 ... Researchers detail in 'Looking for an active conformation of the future HIV type-1 non-nucleoside reverse transcriptase inhibitors,' new data in antivirals. ... key drugs of highly active antiretroviral therapy (HAART) in the clinical management of AIDS/HIV infection. NNRTI-based HAART regimes effectively suppress viral reproduction, are ...
2010 SEP 7 ... Fresh data on HIV/AIDS are presented in the report 'Deep sequencing of the vaginal microbiota of women ... and Mycoses, HIV Infections, HIV/AIDS, Primate Lentiviruses, RNA Viruses, Retroviridae, Therapy, Treatment, Vertebrate Viruses, Viral Sexually Transmitted Diseases, Women's Health. ...
2010 SEP 7 ... Current study results from the report, 'Computational models of HIV-1 resistance to gene therapy elucidate therapy design principles,' have been published. ... Keywords: City:Berkeley, State:California, Country:United States, HIV Infections, HIV/AIDS, Primate Lentiviruses, RNA Viruses, Retroviridae, Vertebrate Viruses, Viral Sexually ...
2010 SEP 7 ... 'Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT ... VL (>or=3, 1-2 or <1) or CD4 (>or=3 or <3) testing. Endpoints were time to AIDS/death and change in CD4 cell count and VL suppression (<400 HIV-1 RNA copies/mL) at ...
2010 SEP 7 ... life year saved is $21 (95% CI, $15-$32). Integrating CRAG screening into HIV care, specifically targeting people with severe immunosuppression (CD4(+) cell count ... "Cryptococcal meningitis (CM) remains a common AIDS-defining illness in Africa and Asia. Subclinical cryptococcal antigenemia is frequently ... Asia. Subclinical cryptococcal antigenemia is frequently unmasked with antiretroviral therapy (ART)," scientists in Kampala, Uganda report. "We sought to define the ...
2010 SEP 7 ... Fresh data on HIV/AIDS are presented in the report 'Ongoing drug use and outcomes from highly active ... in the report 'Ongoing drug use and outcomes from highly active antiretroviral therapy among injection drug users in a Canadian setting.' "The effect of ongoing illicit drug ...
2010 SEP 7 ... Researchers detail in 'Pharmacodynamics of PEG-IFN-alpha-2a in HIV/HCV co-infected patients: Implications for treatment outcomes,' new data in HIV/AIDS. ... Pharmacodynamics, Pharmacokinetics, Primate Lentiviruses, RNA Viruses, Retroviridae, Therapy, Treatment, Vertebrate Viruses, Viral Sexually Transmitted Diseases. This ...
2010 SEP 7 ... with a chronic infectious disease. Adolescence is a particularly vulnerable period for HIV-infected people in relation to mental health problems and engagement in high-risk ... conducted with HIV+ adolescents (25) and caregivers of HIV+ children (15) at a large HIV/AIDS Clinic in South Africa. Data were analysed thematically using NVivo8 software. ... According to a study from Durban, South Africa, "While the roll-out of antiretroviral therapy in South Africa should lead to a reduction in mother to child transmission, mortality ...
2010 SEP 7 ... A new study, 'Novel integrase inhibitors for HIV,' is now available. According to recent research from the United States, "IMPORTANCE ... or in earlier phases of development," wrote N. Prada and colleagues, Aaron Diamond AIDS Research Center. The researchers concluded: "Taken together, this class ... Pre Trials Research, Primate Lentiviruses, RNA Viruses, Recombinases, Retroviridae, Therapy, Treatment, Vertebrate Viruses, Viral Sexually Transmitted Diseases. This ...
2010 SEP 7 ... Fresh data on HIV/AIDS are presented in the report 'Second-line treatment in the Malawi antiretroviral ... survivors, despite extensive drug resistance at baseline.' "The Malawi antiretroviral therapy (ART) programme uses the public health approach to identify ART failure. Advanced ...
2010 SEP 7 ... etravirine without and with once-daily darunavir/ritonavir in antiretroviral-naive HIV type-1-infected adults,' are detailed in a study published in Antiviral Therapy. "A ... State:FL, Country:United States, Antiviral, Blood, Darunavir, Drugs, HIV Infections, HIV/AIDS, Pharmaceuticals, Pharmacokinetics, Plasma, Primate Lentiviruses, RNA Viruses, ...
2010 SEP 7 ... genetics may have a role in the occurrence of CMV retinitis in patients infected with HIV." Sezgin and colleagues published their study in the Journal of Infectious ... (CMV) retinitis is a common opportunistic infection among patients with AIDS and still causes visual morbidity despite the wide spread usage of highly active ... causes visual morbidity despite the wide spread usage of highly active antiretroviral therapy (HAART). The ubiquitous CMV pathogen contains a human interleukin-10 (IL-10) homolog in ...
2010 SEP 7 ... have identified two drugs that, when combined, may serve as an effective treatment for HIV. The two drugs, decitabine and gemcitabine - both FDA approved and ... human body when taken orally. Keywords: Cancer, FDA, HIV Infections, HIV/AIDS, Mutagenesis, Oncology, Primate Lentiviruses, RNA Viruses, Regulatory Actions, ... and gemcitabine - both FDA approved and currently used in pre-cancer and cancer therapy - were found to eliminate HIV infection in the mouse model by causing the virus to ...
